The EPO published European patent application EP3893958A1 filed by Revamp Medical Ltd. on March 25, 2026. The invention relates to systems for adjusting blood flow in a body lumen, classified under A61M (medical devices for therapeutic purposes) and A61B (surgical instruments). The application designates all EU/EEA member states for patent validation. This is a publication notice initiating the post-grant opposition window, not a substantive regulatory change.

For compliance purposes, this publication does not create new compliance obligations. However, medical device manufacturers and healthcare providers operating in cardiovascular intervention should monitor the opposition period. Third parties may file observations, and upon patent grant, the holder gains enforceable IP rights in designated states. Entities developing similar blood flow devices should conduct freedom-to-operate analyses.